vTv Therapeutics Inc. Proceeds from Related Party Debt
vTv Therapeutics Inc. (VTVT) reported Proceeds from Related Party Debt of $19.29 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-02-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRelatedPartyDebt · last filed 2018-02-27
- vTv Therapeutics Inc. proceeds from related party debt for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- vTv Therapeutics Inc. proceeds from related party debt for the quarter ending 2015-09-30 was $13.00K.
- vTv Therapeutics Inc. proceeds from related party debt for the quarter ending 2015-06-30 was $10.48M.
- vTv Therapeutics Inc. proceeds from related party debt for the quarter ending 2015-03-31 was $8.80M.
- vTv Therapeutics Inc. proceeds from related party debt for fiscal 2015 was $19.29M, a 42.53% decline from fiscal 2014.
- vTv Therapeutics Inc. proceeds from related party debt for fiscal 2014 was $33.56M, a 14.33% decline from fiscal 2013.
- vTv Therapeutics Inc. proceeds from related party debt for fiscal 2013 was $39.17M.
| Period end | Proceeds from Related Party Debt 3 month | Proceeds from Related Party Debt 6 month | Proceeds from Related Party Debt 9 month | Proceeds from Related Party Debt 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $13.00K derived: sum of 2 quarters · filed 2018-02-27 | $10.49M derived: sum of 3 quarters · filed 2018-02-27 | $19.29M 10-K · filed 2018-02-27 |
| 2015-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $10.49M derived: sum of 2 quarters · filed 2016-11-03 | $19.29M 10-Q · filed 2016-11-03 | $28.95M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-06-30 | $10.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $19.28M 10-Q · filed 2016-08-02 | $28.94M derived: sum of 3 quarters · filed 2017-02-24 | |
| 2015-03-31 | $8.80M 10-Q · filed 2016-05-13 | $18.46M derived: sum of 2 quarters · filed 2017-02-24 | ||
| 2014-12-31 | $9.66M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $33.56M 10-K · filed 2017-02-24 | ||
| 2014-09-30 | $23.90M 10-Q · filed 2015-11-13 | |||
| 2013-12-31 | $39.17M 10-K · filed 2016-03-04 |